Pamapimod

Pamapimod is an investigational drug which is being evaluated for the treatment of autoimmune diseases. It is a p38 mitogen-activated protein kinase inhibitor.^[1] It has been evaluated in a phase 2 clinical trial for the treatment of rheumatoid arthritis, but was found not to be effective.^[2][3] It has subsequently been investigated as a possible treatment for osteoarthritis.^[4][5]

CAS Number

• 449811-01-2

PubChem CID

• 16220188

IUPHAR/BPS

• 9915

ChemSpider

• 17347490

Quick facts Identifiers, CAS Number ...

Pamapimod

Identifiers
IUPAC name 6-(2,4-difluorophenoxy)-2-(1,5-dihydroxypentan-3-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one
CAS Number	449811-01-2
PubChem CID	16220188
IUPHAR/BPS	9915
ChemSpider	17347490
UNII	8S2C9V11K4
KEGG	D08963
ChEBI	CHEBI:90685
ChEMBL	ChEMBL1090089
PDB ligand	FLW (PDBe, RCSB PDB)
CompTox Dashboard (EPA)	DTXSID90963312
Chemical and physical data
Formula	C19H20F2N4O4
Molar mass	406.390 g·mol−1
3D model (JSmol)	Interactive image
SMILES CN1C2=NC(=NC=C2C=C(C1=O)OC3=C(C=C(C=C3)F)F)NC(CCO)CCO
InChI InChI=InChI=1S/C19H20F2N4O4/c1-25-17-11(10-22-19(24-17)23-13(4-6-26)5-7-27)8-16(18(25)28)29-15-3-2-12(20)9-14(15)21/h2-3,8-10,13,26-27H,4-7H2,1H3,(H,22,23,24) Key:JYYLVUFNAHSSFE-UHFFFAOYSA-N

Close